SCHEMBL20520187

SCHEMBL20520187

NC(=O)c1c2nc(c(-c3c(F)cccc3F)c3ccc(cc4nc(c(-c5c(F)cccc5F)c5ccc1[nH]5)C=C4)[nH]3)C=C2

nearest known ligand 0.53

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.46
▸ STAT1 P42224 1/20 0.46
▸ TOP1 P11387 3/20 0.35
▸ CYCS P99999 3/20 0.34
▸ PARP1 P09874 1/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33
▸ ENPP2 Q13822 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20843737 0.87 STAT3 (0.43) STAT3STAT1TOP1CYCSABCG2
SCHEMBL20520075 0.85 STAT3 (0.59) STAT3STAT1TOP1
SCHEMBL6092415 0.83 STAT3 (0.43) STAT3STAT1TOP1CYCSPARP1
SCHEMBL6094135 0.81 STAT3 (0.45) STAT3STAT1TOP1PARP1
SCHEMBL28539046 0.81 STAT3 (0.50) STAT3STAT1TOP1CYCS
SCHEMBL20520148 0.79 STAT3 (0.38) STAT3STAT1CYCSPARP1
SCHEMBL20843716 0.78 STAT3 (0.39) STAT3STAT1ABCG2
SCHEMBL28539011 0.76 STAT3 (0.43) STAT3STAT1TOP1
SCHEMBL8977875 0.76 STAT3 (0.69) STAT3STAT1TOP1CYCSABCG2
SCHEMBL30426808 0.75 STAT3 (0.56) STAT3STAT1TOP1CYCSENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107624114-B Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and uses thereof 卢西蒂恩股份有限公司 2021-03-23 — — CN disclosed
US-10450322-B2 Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof LUZITIN, S.A. (PT) 2019-10-22 — — US disclosed
EP-3292129-B1 LOW MOLECULAR WEIGHT HALOGENATED PORPHYRINE CARBOXAMIDE CHLORIN AND BACTERIOCHLORIN DERIVATIVES FOR USE IN PHOTODYNAMIC THERAPY FOR TREATING CANCER LUZITIN S A (PT) 2019-03-27 — — EP disclosed
US-20180282344-A1 LOW MOLECULAR WEIGHT DERIVATIVES OF CARBOXAMIDE HALOGENATED PORPHYRINS, NAMELY CHLORINS AND BACTERIOCHLORINS, AND THEIR APPLICATIONS THEREOF LUZITIN, S.A. (PT) 2018-10-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450322-B2 Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof CRY1, PPIA, PPOX STAT3 361/4885STAT1 833/4885TOP1 1536/4885
US-20180282344-A1 LOW MOLECULAR WEIGHT DERIVATIVES OF CARBOXAMIDE HALOGENATED PORPHYRINS, NAMELY CHLORINS AND BACTERIOCHLORINS, AND THEIR APPLICATIONS THEREOF CRY1, PPIA, PPOX STAT3 361/4885STAT1 833/4885TOP1 1536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback